Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome

Clinical Biochemistry
Sepideh MansoubKhosrow Adeli

Abstract

The childhood obesity epidemic has begun to compromise the health of the pediatric population by promoting premature development of atherosclerosis and the metabolic syndrome (MS), both of which significantly increase the risk of cardiovascular disease (CVD) early in life. As a result, recently, there has been increased recognition of the need to assess and closely monitor children and adolescents for risk factors of CVD and components of the MS. Serum/Plasma biomarkers including total cholesterol, triglycerides, HDL-C, LDL-C, insulin and C-peptide have been used for this purpose for many years. Recently, emerging biomarkers such as apolipoprotein AI, apolipoprotein B, leptin, adiponectin, free fatty acids, and ghrelin have been proposed as tools that provide valuable complementary information to that obtained from traditional biomarkers, if not more powerful predictions of risk. In order for biomarkers to be clinically useful in accurately diagnosing and treating disorders, age-specific reference intervals that account for differences in gender, pubertal stage, and ethnic origin are a necessity. Unfortunately, to date, many critical gaps exist in the reference interval database of most of the biomarkers that have been identifi...Continue Reading

References

Jun 1, 1978·European Journal of Clinical Investigation·T IshikawaN E Miller
Nov 1, 1978·The American Journal of the Medical Sciences·H G WilcoxS Schenker
Nov 1, 1977·The American Journal of Digestive Diseases·O Gunnlaugsson, D Berkowitz
Jun 1, 1976·Endocrinology·R S SwerdloffG A Bray
May 15, 1992·The American Journal of Cardiology·G SigurdssonN Sigfusson
Dec 1, 1991·Mayo Clinic Proceedings·B A KottkeW H Weidman
Aug 8, 1991·The New England Journal of Medicine·M J StampferC H Hennekens
Apr 1, 1988·Metabolism: Clinical and Experimental·B M WolfeR R Wolfe
Oct 8, 1965·Annals of the New York Academy of Sciences·P J RandleC N Hales
Apr 1, 1966·The Journal of Clinical Endocrinology and Metabolism·R Caren, L Corbo
Nov 1, 1983·The Journal of Clinical Investigation·E FerranniniR A DeFronzo
Nov 1, 1982·Metabolism: Clinical and Experimental·D ThiébaudJ P Felber
Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·O A MacDougaldM D Lane
Nov 10, 1995·The Journal of Biological Chemistry·P E SchererH F Lodish
Jul 1, 1995·Physiological Reviews·G M Reaven
Jul 28, 1995·Science·M A PelleymounterF Collins
Dec 16, 1994·Diabetes Research and Clinical Practice·T ShimizuA Sasaki
Jul 1, 1993·The Journal of Clinical Investigation·D E KelleyL J Mandarino
Feb 1, 1996·The New England Journal of Medicine·R V ConsidineT L Bauer
Jan 22, 1996·FEBS Letters·J Rentsch, M Chiesi
Sep 1, 1995·Obesity Research·Y MatsuzawaK Tokunaga
Apr 16, 1996·Biochemical and Biophysical Research Communications·K MaedaK Matsubara
May 1, 1996·The Journal of Pediatrics·O Pinhas-HamielP Zeitler
May 3, 1996·The Journal of Biological Chemistry·E HuB M Spiegelman
Mar 1, 1996·The Journal of Clinical Investigation·M K SinhaJ F Caro

❮ Previous
Next ❯

Citations

Jul 4, 2012·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·C CaselliD Giannessi
Mar 2, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Massimiliano CantinottiAldo Clerico
Feb 4, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Massimiliano CantinottiAldo Clerico
Oct 31, 2009·Psychiatric Genetics·Chadi A CalargeJanet A Schlechte
Aug 3, 2012·European Journal of Pediatrics·Polyxeni KarakostaLeda Chatzi
Mar 13, 2014·Current Problems in Pediatric and Adolescent Health Care·Roya Kelishadi, Parinaz Poursafa
Jan 26, 2016·Metabolic Syndrome and Related Disorders·Harry Robberecht, Nina Hermans
Jul 30, 2010·Nitric Oxide : Biology and Chemistry·Asghar GhasemiFereidoun Azizi
Jul 14, 2009·Clinical Biochemistry·Benjamin Jung, Khosrow Adeli
Apr 21, 2007·Journal of Hepatology·Eve A Roberts
May 17, 2015·Clinical Biochemistry·Mohamed Abou El HassanKhosrow Adeli
Jul 15, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ulrik Lausten-ThomsenJens-Christian Holm
Nov 17, 2009·Journal of Internal Medicine·P HennemanK Willems van Dijk
Sep 30, 2009·Acta Paediatrica·Susanne ErikssonBirgitta Strandvik
May 10, 2013·Critical Reviews in Clinical Laboratory Sciences·Julie L V ShawKhosrow Adeli
Jan 21, 2015·Cardiology in the Young·Massimiliano CantinottiAldo Clerico
Nov 22, 2014·PloS One·Francesco SavinoLeandra Silvestro
Dec 29, 2016·International Journal of Food Sciences and Nutrition·Harry RobberechtNina Hermans
Mar 10, 2017·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Harry RobberechtNina Hermans
Mar 27, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·P BrambillaA Pietrobelli
Nov 8, 2014·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J PepliesW Ahrens
Apr 12, 2007·Pediatric Research·Yacine Aggoun
Mar 20, 2010·The Journal of Clinical Endocrinology and Metabolism·Sina GalloStan Kubow
May 18, 2019·International Journal of Molecular Sciences·Jolanta Patro-MałyszaBożena Leszczyńska-Gorzelak
Jan 13, 2015·Clinical Chemistry and Laboratory Medicine : CCLM·Sophia SakkaIoannis Papassotiriou
Jul 21, 2017·Journal of Pediatric Endocrinology & Metabolism : JPEM·Navindra PersaudUNKNOWN TARGet Kids! collaboration

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.